Sharp Therapeutics Corp. (TSXV:SHRX)
Canada · Delayed Price · Currency is CAD 1.370
0.00 (0.00%)
At close: Sep 21, 2026
Sharp Therapeutics Market Cap
Sharp Therapeutics has a market cap or net worth of CAD 43.26 million as of October 9, 2026. It is the 34,147th most valuable company in the world and the 1,022nd biggest in Canada. Its market cap has increased by 188.67% in one year.
Market Cap
43.26M
Enterprise Value
46.32M
Revenue
n/a
Global Rank
Country Rank
#1,022 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since January 17, 2025, Sharp Therapeutics's market cap has decreased from 62.09M to 43.26M, a decrease of -30.32%. That is a compound annual growth rate of -19.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 43.26M | -42.35% |
| Dec 30, 2025 | 75.03M | 20.85% |
| Jan 17, 2025 | 62.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 60.78M |
| NurExone Biologic | 56.87M |
| BriaCell Therapeutics | 49.50M |
| Sernova Biotherapeutics | 45.32M |
| Microbix Biosystems | 43.15M |
| MedMira | 42.10M |
| Medicenna Therapeutics | 41.54M |
| Sona Nanotech | 40.52M |